These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Burkholderia cepacia in cystic fibrosis. Govan JR N Engl J Med; 1995 Mar; 332(12):819-20; author reply 820-1. PubMed ID: 7532285 [No Abstract] [Full Text] [Related]
3. Burkholderia cepacia in cystic fibrosis. Mahenthiralingam E; Campbell M; Speert DP N Engl J Med; 1995 Mar; 332(12):819. PubMed ID: 7532284 [No Abstract] [Full Text] [Related]
4. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis. Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050 [TBL] [Abstract][Full Text] [Related]
5. Bacterial contaminants in cosmetic products from a patient with cystic fibrosis. O'Gorman K; Xu J; Elborn JS; Boyle L; Millar BC; Goldsmith CE; Moore JE Br J Biomed Sci; 2006; 63(3):141-2. PubMed ID: 17058716 [No Abstract] [Full Text] [Related]
6. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. Steinbach S; Sun L; Jiang RZ; Flume P; Gilligan P; Egan TM; Goldstein R N Engl J Med; 1994 Oct; 331(15):981-7. PubMed ID: 7521938 [TBL] [Abstract][Full Text] [Related]
7. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients]. Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760 [TBL] [Abstract][Full Text] [Related]
8. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. Kiska DL; Kerr A; Jones MC; Caracciolo JA; Eskridge B; Jordan M; Miller S; Hughes D; King N; Gilligan PH J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102 [TBL] [Abstract][Full Text] [Related]
9. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production. Carvalho AP; Ventura GM; Pereira CB; Leão RS; Folescu TW; Higa L; Teixeira LM; Plotkowski MC; Merquior VL; Albano RM; Marques EA APMIS; 2007 Apr; 115(4):311-8. PubMed ID: 17504297 [TBL] [Abstract][Full Text] [Related]
10. Pseudomonas (Burkholderia) cepacia in children with cystic fibrosis: epidemiological investigation by analysis or restriction fragment length polymorphism. Valcin M; Moissenet D; Sardet A; Tournier G; Garbarg-Chenon A; Vu-Thien H Pathol Biol (Paris); 1996 May; 44(5):442-6. PubMed ID: 8758491 [TBL] [Abstract][Full Text] [Related]
11. Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients. Nir M; Johansen HK; Høiby N Acta Paediatr; 1992 Dec; 81(12):1042-3. PubMed ID: 1283959 [No Abstract] [Full Text] [Related]
12. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection. Bernhardt SA; Spilker T; Coffey T; LiPuma JJ Clin Infect Dis; 2003 Sep; 37(6):780-5. PubMed ID: 12955638 [TBL] [Abstract][Full Text] [Related]
13. Pseudomonas cepacia at summer camps for persons with cystic fibrosis. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1993 Jun; 42(23):456-9. PubMed ID: 7684813 [TBL] [Abstract][Full Text] [Related]
14. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691 [TBL] [Abstract][Full Text] [Related]
15. Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis. Geisenberger O; Givskov M; Riedel K; Høiby N; Tümmler B; Eberl L FEMS Microbiol Lett; 2000 Mar; 184(2):273-8. PubMed ID: 10713433 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients. Traczewski MM; Brown SD Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756 [TBL] [Abstract][Full Text] [Related]
17. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? Butler SL; Doherty CJ; Hughes JE; Nelson JW; Govan JR J Clin Microbiol; 1995 Apr; 33(4):1001-4. PubMed ID: 7540623 [TBL] [Abstract][Full Text] [Related]